Reports for GLAXOSMITHKLINE INC
Company Name
GLAXOSMITHKLINE INC
Totals |
||
Shortage reports |
322 |
|
| Actual shortage: | 8 (2%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 6 (2%) | |
| Resolved: | 308 (96%) | |
Discontinuation Reports |
56 |
|
| To be discontinued: | 2 (4%) | |
| Discontinued: | 54 (96%) | |
| Reversed: | 0 (0%) | |
Late reports |
4 (1%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CLINDOXYL GEL | 1% 5% | GEL | Resolved | 2022-02-11 | 2022-04-13 | 154785 |
| CLINDOXYL GEL | 1% 5% | GEL | Resolved | 2022-09-23 | 2022-11-02 | 170085 |
| CLINDOXYL GEL | 1% 5% | GEL | Resolved | 2023-06-08 | 2023-06-17 | 193899 |
| CLINDOXYL GEL | 1% 5% | GEL | Resolved | 2023-06-30 | 2023-08-30 | 196974 |
| CLINDOXYL GEL | 1% 5% | GEL | Resolved | 2023-09-08 | 2024-03-13 | 203953 |
| CLINDOXYL ADV GEL | 3% 1% | GEL | Resolved | 2017-07-28 | 2017-09-27 | 17444 |
| CLINDOXYL ADV GEL | 3% 1% | GEL | Resolved | 2017-10-06 | 2017-11-22 | 24666 |
| CLINDOXYL ADV GEL | 3% 1% | GEL | Resolved | 2019-10-18 | 2019-11-30 | 96823 |
| CLINDOXYL ADV GEL | 3% 1% | GEL | Resolved | 2020-05-22 | 2021-02-17 | 115612 |
| CLINDOXYL ADV GEL | 1% 3% | GEL | Resolved | 2023-08-03 | 2024-02-16 | 200926 |
| STIEVA-A | 0.05% | CREAM | Resolved | 2019-11-08 | 2019-12-06 | 98223 |
| STIEVA-A | 0.05% | CREAM | Resolved | 2020-05-08 | 2020-07-15 | 114294 |
| STIEVA-A | 0.05% | CREAM | Resolved | 2021-11-17 | 2022-01-05 | 149516 |
| STIEVA-A | 0.05% | CREAM | Resolved | 2022-09-23 | 2022-11-09 | 170091 |
| STIEVA-A | 0.025% | CREAM | Resolved | 2020-05-08 | 2020-06-24 | 114291 |
| STIEVA-A | 0.025% | CREAM | Resolved | 2020-07-10 | 2020-09-02 | 119953 |
| STIEVA-A | 0.025% | CREAM | Resolved | 2021-03-12 | 2021-03-24 | 135587 |
| STIEVA-A | 0.025% | CREAM | Resolved | 2021-05-28 | 2021-06-03 | 140091 |
| STIEVA-A | 0.025% | CREAM | Resolved | 2021-12-03 | 2022-03-09 | 150448 |
| STIEVA-A | 0.025% | CREAM | Resolved | 2022-07-29 | 2022-11-02 | 165701 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MESASAL | 500MG | TABLET (ENTERIC-COATED) | Discontinued | 2017-03-17 | 2017-03-24 | 3333 |
| AVANDAMET | 500MG 2MG | TABLET | Discontinued | 2017-04-25 | 2017-04-26 | 8077 |
| AVANDAMET | 1000MG 2.00MG | TABLET | Discontinued | 2017-04-25 | 2017-04-26 | 8081 |
| AVANDAMET | 1000MG 4.00MG | TABLET | Discontinued | 2017-04-25 | 2017-04-26 | 8084 |
| AVANDAMET | 500MG 4MG | TABLET | Discontinued | 2017-04-25 | 2017-05-04 | 8087 |
| REQUIP | 0.25MG | TABLET | Discontinued | 2017-09-19 | 2017-11-01 | 22594 |
| REQUIP | 1MG | TABLET | Discontinued | 2017-09-19 | 2018-03-15 | 22597 |
| REQUIP | 2MG | TABLET | Discontinued | 2017-09-19 | 2018-03-15 | 22600 |
| REQUIP | 5MG | TABLET | Discontinued | 2017-09-19 | 2018-03-15 | 22603 |
| ZANTAC | 150MG | TABLET | Discontinued | 2017-09-19 | 2017-09-19 | 22611 |
| ZANTAC | 300MG | TABLET | Discontinued | 2017-09-19 | 2017-09-19 | 22614 |
| AVANDIA | 2MG | TABLET | Discontinued | 2020-04-27 | 2020-09-01 | 113311 |
| AVANDIA | 4MG | TABLET | Discontinued | 2020-04-27 | 2020-12-11 | 113314 |
| AVANDIA | 8MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113317 |
| CEFTIN - TAB 250MG | 250MG | TABLET | Discontinued | 2020-07-24 | 2020-07-24 | 121046 |
| CEFTIN - TAB 500MG | 500MG | TABLET | Discontinued | 2020-07-24 | 2020-07-24 | 121049 |
| AMERGE | 1MG | TABLET | Discontinued | 2021-10-28 | 2022-08-09 | 148427 |
| AMERGE | 2.5MG | TABLET | Discontinued | 2021-10-28 | 2022-12-02 | 148430 |
| HEPTOVIR | 100MG | TABLET | Discontinued | 2022-05-13 | 2022-08-10 | 160500 |
| CLAVULIN 875 | 125MG 875MG | TABLET | Discontinued | 2024-01-18 | 2024-01-18 | 216509 |